ALNW:Intracerebral hemorrhage - Revision history

Danbot: Danbot moved page ALNW:Intracerebral Hemorrhage to ALNW:Intracerebral hemorrhage: Naming convention: first word capitalized, subsequent words lowercase

2026-03-22T02:38:50Z

Danbot moved page ALNW:Intracerebral Hemorrhage to ALNW:Intracerebral hemorrhage: Naming convention: first word capitalized, subsequent words lowercase

← Older revision	Revision as of 02:38, 22 March 2026
(No difference)

2017-08-13T01:19:00Z

Text replacement - "beta blocker" to "β-blocker"

← Older revision		Revision as of 01:19, 13 August 2017
Line 26:		Line 26:

	===Management of hypertension===		===Management of hypertension===
	*[[Labetalol]]: short-acting ~~beta~~ blocker, quick onset, anti-hypertensive agent		*[[Labetalol]]: short-acting β-blocker, quick onset, anti-hypertensive agent
	**Indication:		**Indication:
	***Flight < 30 minutes		***Flight < 30 minutes

2016-12-27T05:37:46Z

Redirecting to "institution-specific" category

← Older revision		Revision as of 05:37, 27 December 2016
Line 69:		Line 69:
	*Consider foley catheter for interfacility transfers		*Consider foley catheter for interfacility transfers

	[[Category:~~EMS~~]]		[[Category:Admin]]

2016-07-30T10:39:03Z

Text replacement - "HTN" to "hypertension"

← Older revision		Revision as of 10:39, 30 July 2016
Line 37:		Line 37:
	***HR <60.		***HR <60.
	***SBP <100: turn drip off and give IV bolus of 250-500ml crystalloid		***SBP <100: turn drip off and give IV bolus of 250-500ml crystalloid
	*[[Nitrates]] or [[nitroprusside]] initiated by referring facility for hypertension should be discontinued for transport. ~~HTN~~ will be managed following guidelines above.		*[[Nitrates]] or [[nitroprusside]] initiated by referring facility for hypertension should be discontinued for transport. hypertension will be managed following guidelines above.

	===Management of hypotension===		===Management of hypotension===

2016-07-27T04:05:28Z

Text replacement - "0 ml" to "0ml"

← Older revision		Revision as of 04:05, 27 July 2016
Line 41:		Line 41:
	===Management of hypotension===		===Management of hypotension===
	*Discuss threshold for utilization of vasopressors (and type) with medical control even if the patient is normotensive. If on anti-hypertensive infusion, consider titrating or stopping medication.		*Discuss threshold for utilization of vasopressors (and type) with medical control even if the patient is normotensive. If on anti-hypertensive infusion, consider titrating or stopping medication.
	**Prehospital: If two consecutive systolic BP < 100, fluid bolus 250-~~500 ml~~ increments, if no immediate contact available with medical control. In discussion with medical control, consider [[phenylephrine]] or [[norepinephrine]] for BP unresponsive to fluids.		**Prehospital: If two consecutive systolic BP < 100, fluid bolus 250-500ml increments, if no immediate contact available with medical control. In discussion with medical control, consider [[phenylephrine]] or [[norepinephrine]] for BP unresponsive to fluids.
	**Interfacility: For systolic BP < 100, consider fluids as above and discuss addition of vasopressors as above with medical control. Maintain normothermia.		**Interfacility: For systolic BP < 100, consider fluids as above and discuss addition of vasopressors as above with medical control. Maintain normothermia.

2016-07-22T14:23:33Z

Text replacement - " pt " to " patient "

← Older revision		Revision as of 14:23, 22 July 2016
Line 45:		Line 45:

	===Coagulopathy===		===Coagulopathy===
	*Consider [[FFP]] and [[Vitamin K]] (IFT) if patient is excessively anti-coagulated( INR > 1.5, pt on [[ASA]] or [[clopidigrel]]. Consult with [[Medical Control]].		*Consider [[FFP]] and [[Vitamin K]] (IFT) if patient is excessively anti-coagulated( INR > 1.5, patient on [[ASA]] or [[clopidigrel]]. Consult with [[Medical Control]].
	*Consider [[platelets]] if [[platelet count]] < 100K. Consult with Medical Control.		*Consider [[platelets]] if [[platelet count]] < 100K. Consult with Medical Control.

2016-05-11T13:58:50Z

← Older revision		Revision as of 13:58, 11 May 2016
Line 68:		Line 68:
	==GU==		==GU==
	*Consider foley catheter for interfacility transfers		*Consider foley catheter for interfacility transfers

			[[Category:EMS]]

2016-05-03T02:47:39Z

← Older revision		Revision as of 02:47, 3 May 2016
Line 32:		Line 32:
	***HR > 60		***HR > 60
	**Contraindications: HR < 60		**Contraindications: HR < 60
	*[[ALNW:~~nicardipine~~\|Nicardipine]]: short-acting, titrateable, calcium channel blocker (vasodilator)		*[[ALNW:Nicardipine\|Nicardipine]]: short-acting, titrateable, calcium channel blocker (vasodilator)
	**Indication:		**Indication:
	***Flight longer than 30 minutes		***Flight longer than 30 minutes
	***HR < 60.		***HR <60.
	***SBP < 100: turn drip off and give IV bolus of 250-~~500 cc~~ crystalloid		***SBP <100: turn drip off and give IV bolus of 250-500ml crystalloid
	*[[Nitrates]] or [[nitroprusside]] initiated by referring facility for hypertension should be discontinued for transport. HTN will be managed following guidelines above.		*[[Nitrates]] or [[nitroprusside]] initiated by referring facility for hypertension should be discontinued for transport. HTN will be managed following guidelines above.

2016-05-03T02:44:31Z

← Older revision	Revision as of 02:44, 3 May 2016
(No difference)

2016-05-02T22:01:44Z

← Older revision		Revision as of 22:01, 2 May 2016
Line 20:		Line 20:
	***antihypertensives after 1x SBP >220 or DBP> 120		***antihypertensives after 1x SBP >220 or DBP> 120
	**'''Interfacility: (confirmed by CT)'''		**'''Interfacility: (confirmed by CT)'''
	***ICH: SBP 140-160		***[[ICH]]: SBP 140-160
	****antihypertensives after 2x SBP >160		****antihypertensives after 2x SBP >160
	***SAH: SBP 100-120		***[[SAH]]: SBP 100-120
	****antihypertensives after 2x SBP >120		****antihypertensives after 2x SBP >120

Line 32:		Line 32:
	***HR > 60		***HR > 60
	**Contraindications: HR < 60		**Contraindications: HR < 60
	*[[nicardipine ~~(ALNW)~~\|Nicardipine]]: short-acting, titrateable, calcium channel blocker (vasodilator)		*[[ALNW:nicardipine\|Nicardipine]]: short-acting, titrateable, calcium channel blocker (vasodilator)
	**Indication:		**Indication:
	***Flight longer than 30 minutes		***Flight longer than 30 minutes